Latest News

FDA warns against widespread use of hydroxychloroquine, drug touted by Trump



The Food and Drug Administration on Friday cautioned against the use of hydroxychloroquine, a malaria drug originally approved in 1955, to treat Covid-19 outside of the hospital or in the setting of a clinical trial. The drug has been repeatedly touted by President Trump as a potential treatment.

In a drug safety communication meant for health care providers, the FDA said it is “aware of reports of serious heart rhythm problems” in patients with Covid-19 treated with hydroxychloroquine or an older drug, chloroquine. The agency said it seeks to “remind health care professionals and patients of the known risks associated with both hydroxychloroquine and chloroquine.”

Read the rest…

Source link

Related posts

Brainlab unveils ExacTrac Dynamic at ASTRO meeting in San Antonio, Texas

Newsemia

COVID-19 Blood Test Might Predict Who Will Need a Ventilator

Newsemia

Medical News Today: Why are researchers growing human protein in hens' eggs?

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World